FCRX vs IONS · P/E 177, $132.8M cap vs rev $514.0M
First Eagle Alternative Capital BDC Inc (FCRX) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
First Eagle Alternative Capital BDC Inc (FCRX) common stock listed on NYSE.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
FCRX does not have a complete income-statement cache yet.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
FCRX currently screens at market cap $132.8M and trailing P/E 177.3. IONS currently screens at market cap $12.28B.
Not investment advice. Open the FCRX and IONS stock pages for the full models.
Not investment advice.